RS50768B - Režim doziranja i farmaceutska formulacija za urgentnu zaštitu - Google Patents

Režim doziranja i farmaceutska formulacija za urgentnu zaštitu

Info

Publication number
RS50768B
RS50768B YUP-42/04A YUP4204A RS50768B RS 50768 B RS50768 B RS 50768B YU P4204 A YUP4204 A YU P4204A RS 50768 B RS50768 B RS 50768B
Authority
RS
Serbia
Prior art keywords
pharmaceutical composition
dosage regimen
emergency contraception
formulation
contraception
Prior art date
Application number
YUP-42/04A
Other languages
English (en)
Inventor
Paul F.A. Van Look
Illésné BALOGH
Katalin KOMÁNDI
László NEMES
Zsolt SZABÓ
Original Assignee
Richter Gedeon Vegyészeti Gyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyészeti Gyár Rt. filed Critical Richter Gedeon Vegyészeti Gyár Rt.
Publication of RS4204A publication Critical patent/RS4204A/sr
Publication of RS50768B publication Critical patent/RS50768B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

Farmaceutska kompozicija u obliku jedinične doze, naznačena time, što kao aktivnu komponentu sadrži 1.5±0.2 mg levonorgestrela , u smeši sa poznatim ekscipientima, diluentima, veštačkim pojačivačima ukusa i arome, stabilizatorima, kao i sa aditivima koji se nalaze u formulaciji ili potpomažu formulaciju, a koji se uobičajeno koriste u farmaceutskoj praksi. Prijava sadrži još 2 patentna zahteva.
YUP-42/04A 2001-11-27 2002-11-26 Režim doziranja i farmaceutska formulacija za urgentnu zaštitu RS50768B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
RS4204A RS4204A (en) 2007-02-05
RS50768B true RS50768B (sr) 2010-08-31

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-42/04A RS50768B (sr) 2001-11-27 2002-11-26 Režim doziranja i farmaceutska formulacija za urgentnu zaštitu

Country Status (33)

Country Link
US (1) US20050288264A2 (sr)
EP (1) EP1448207B1 (sr)
JP (1) JP2005516904A (sr)
KR (1) KR100908161B1 (sr)
CN (1) CN1551774A (sr)
AP (1) AP1849A (sr)
AT (1) ATE293978T1 (sr)
AU (1) AU2002347401A1 (sr)
BR (1) BR0210595A (sr)
CA (1) CA2450359C (sr)
DE (1) DE60203929T2 (sr)
DK (1) DK1448207T3 (sr)
EA (1) EA006545B1 (sr)
EC (1) ECSP045171A (sr)
ES (1) ES2239727T3 (sr)
GE (1) GEP20063882B (sr)
HR (1) HRP20040584B1 (sr)
HU (1) HU227198B1 (sr)
IL (1) IL159394A0 (sr)
IS (1) IS2691B (sr)
MA (1) MA27076A1 (sr)
MX (1) MXPA04005104A (sr)
NO (1) NO333984B1 (sr)
NZ (1) NZ530056A (sr)
OA (1) OA12730A (sr)
PL (1) PL206010B1 (sr)
PT (1) PT1448207E (sr)
RS (1) RS50768B (sr)
SI (1) SI1448207T1 (sr)
TN (1) TNSN04048A1 (sr)
UA (1) UA79942C2 (sr)
WO (1) WO2003045397A1 (sr)
ZA (1) ZA200404114B (sr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
CA2745541C (en) 2008-12-12 2016-11-08 Laboratoire Hra-Pharma A method for contraception
LT2419108T (lt) 2009-04-14 2016-12-27 Laboratoire Hra Pharma Kontracepcijos pagal poreikį būdas
PE20120860A1 (es) * 2009-06-23 2012-07-15 Bayer Ip Gmbh Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
CN103703014A (zh) 2011-06-01 2014-04-02 埃斯特拉公司 用于产生雌四醇中间体的方法
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
LT2741824T (lt) * 2011-08-11 2017-06-26 Estetra S.P.R.L. Estetrolio panaudojimas kaip skubaus kontraceptiko
AP2015008437A0 (en) 2012-11-22 2015-05-31 Bayer Pharma AG Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
MA38606A1 (fr) 2013-05-23 2017-03-31 Bayer Pharma AG Composition pharmaceutique et son utilisation, ainsi que schéma d'emploi de cette composition pharmaceutique pour la contraception à la demande
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
PT3310346T (pt) 2015-06-18 2021-04-22 Estetra Sprl Comprimido orodispersível contendo estetrol
EP3310345B1 (en) 2015-06-18 2021-03-31 Estetra SPRL Orodispersible tablet containing estetrol
ES2671160T3 (es) 2015-06-18 2018-06-05 Mithra Pharmaceuticals S.A. Unidad de dosificación orodispersable que contiene un componente estetrol
EA035687B1 (ru) 2015-06-18 2020-07-27 Эстетра Спрл Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
NO333984B1 (no) 2013-11-04
ECSP045171A (es) 2004-08-27
EP1448207B1 (en) 2005-04-27
ZA200404114B (en) 2005-10-26
RS4204A (en) 2007-02-05
GEP20063882B (en) 2006-07-25
AU2002347401A1 (en) 2003-06-10
PT1448207E (pt) 2005-08-31
HU227198B1 (en) 2010-10-28
HRP20040584A2 (en) 2005-02-28
ATE293978T1 (de) 2005-05-15
PL206010B1 (pl) 2010-06-30
HRP20040584B1 (en) 2012-11-30
EP1448207A1 (en) 2004-08-25
CA2450359C (en) 2011-05-10
IL159394A0 (en) 2004-06-01
SI1448207T1 (en) 2005-10-31
AP1849A (en) 2008-05-23
EA006545B1 (ru) 2006-02-24
KR100908161B1 (ko) 2009-07-16
PL369520A1 (en) 2005-04-18
MA27076A1 (fr) 2004-12-20
IS2691B (is) 2010-10-15
TNSN04048A1 (en) 2006-06-01
AP2004003046A0 (en) 2004-06-30
HUP0105173A3 (en) 2004-03-29
DE60203929T2 (de) 2006-01-19
OA12730A (fr) 2006-06-28
IS7065A (is) 2003-12-05
US20050032755A1 (en) 2005-02-10
EA200400731A1 (ru) 2004-12-30
HUP0105173A2 (hu) 2003-08-28
HUP0105173D0 (en) 2002-02-28
ES2239727T3 (es) 2005-10-01
US20050288264A2 (en) 2005-12-29
NO20041607L (no) 2004-04-20
UA79942C2 (en) 2007-08-10
MXPA04005104A (es) 2004-08-19
KR20040066088A (ko) 2004-07-23
DE60203929D1 (de) 2005-06-02
CA2450359A1 (en) 2003-06-05
NZ530056A (en) 2005-02-25
BR0210595A (pt) 2004-06-08
WO2003045397A1 (en) 2003-06-05
JP2005516904A (ja) 2005-06-09
DK1448207T3 (da) 2005-06-27
CN1551774A (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
CU20000176A7 (es) Composiciones de celecoxib
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
EA200401009A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
SE0001899D0 (sv) New compounds
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
DK1414467T3 (da) Topisk behandling af mastalgi
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
SE0001916D0 (sv) Novel formulation
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
DE60309472D1 (de) Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
SE0000303D0 (sv) Novel compounds
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
ES2165734T3 (es) Composiciones basadas en pentoxifilina y anticitoquina.